---
figid: PMC5629438__CEI-190-167-g003
figtitle: 'Intracellular and Extracellular mode of Toll‐like receptor (TLR) signalling
  pathways: signalling heterogeneity in TLR pathways arises from the differential
  recognition of pathogen‐associated molecular patterns (PAMPs) by different TLRs'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5629438
filename: CEI-190-167-g003.jpg
figlink: /pmc/articles/PMC5629438/figure/cei13014-fig-0003/
number: F3
caption: 'Intracellular and Extracellular mode of Toll‐like receptor (TLR) signalling
  pathways: signalling heterogeneity in TLR pathways arises from the differential
  recognition of pathogen‐associated molecular patterns (PAMPs) by different TLRs.
  In uninfected macrophages, TLR dimers are presumed to exist in a low‐affinity binding
  state. The binding of ligand is suggested to induce a conformational change that
  brings two Toll/IL‐1 receptor (TIR) domains into the close proximity of each other
  creating the signalling platform necessary for the recruitment of different adaptor
  molecules. Upon ligand binding, TLRs recruit major adaptor proteins: myeloid differentiation
  factor 88 (MyD88) and MyD88‐like adaptor protein/Toll IL receptor‐TIR domain containing
  adaptor‐like protein (MAL/TIRAP). MyD88 contains a C‐terminal TIR domain and an
  N‐terminal death domain, which is known to recruit the serine/threonine kinases
  of the IL‐1 receptor associated kinase (IRAK) family. MAL/TIRAP is essential for
  TLR‐2 and TLR‐4 to signal through the MyD88 pathway. TRIF (TIR domain containing
  adaptor protein inducing IFN‐γ) or TRAM (TRIF‐related adaptor molecule) signal from
  the cytosolic region of TIR domain of the intracellular TLR‐3 and TLR‐4 leading
  to the activation of Interferon regulatory factor (IRF)‐3 via tank binding kinase
  (TBK)‐1 and I kappa B kinase (IKK)ɛ.'
papertitle: Redundant and regulatory roles for Toll‐like receptors in Leishmania infection.
reftext: P. Chauhan, et al. Clin Exp Immunol. 2017 Nov;190(2):167-186.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9731231
figid_alias: PMC5629438__F3
figtype: Figure
redirect_from: /figures/PMC5629438__F3
ndex: ef4e5aed-dec3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5629438__CEI-190-167-g003.html
  '@type': Dataset
  description: 'Intracellular and Extracellular mode of Toll‐like receptor (TLR) signalling
    pathways: signalling heterogeneity in TLR pathways arises from the differential
    recognition of pathogen‐associated molecular patterns (PAMPs) by different TLRs.
    In uninfected macrophages, TLR dimers are presumed to exist in a low‐affinity
    binding state. The binding of ligand is suggested to induce a conformational change
    that brings two Toll/IL‐1 receptor (TIR) domains into the close proximity of each
    other creating the signalling platform necessary for the recruitment of different
    adaptor molecules. Upon ligand binding, TLRs recruit major adaptor proteins: myeloid
    differentiation factor 88 (MyD88) and MyD88‐like adaptor protein/Toll IL receptor‐TIR
    domain containing adaptor‐like protein (MAL/TIRAP). MyD88 contains a C‐terminal
    TIR domain and an N‐terminal death domain, which is known to recruit the serine/threonine
    kinases of the IL‐1 receptor associated kinase (IRAK) family. MAL/TIRAP is essential
    for TLR‐2 and TLR‐4 to signal through the MyD88 pathway. TRIF (TIR domain containing
    adaptor protein inducing IFN‐γ) or TRAM (TRIF‐related adaptor molecule) signal
    from the cytosolic region of TIR domain of the intracellular TLR‐3 and TLR‐4 leading
    to the activation of Interferon regulatory factor (IRF)‐3 via tank binding kinase
    (TBK)‐1 and I kappa B kinase (IKK)ɛ.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - TLR4
  - TLR2
  - TLR6
  - TLR5
  - CD14
  - NDUFA2
  - LY96
  - TIRAP
  - MAL
  - MRTFA
  - MYD88
  - IRAK1
  - IRAK2
  - TLR3
  - IRAK4
  - TRIM69
  - TICAM1
  - TLR8
  - TLR7
  - TRAF6
  - TLR9
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TRAF3
  - TAB2
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - TAB3
  - TAB1
  - MAP2K1
  - MAP2K7
  - MAP2K2
  - CHUK
  - TBK1
  - IKBKB
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - IKBKE
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - NFKBIA
  - ELK1
  - KCNH4
  - KCNH8
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - IRF3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - IRF7
  - IL12A
  - IL12B
  - TNF
  - IL6
  - IFNB1
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - MAP3K7
  - NR2C2
  - IKBKG
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
---
